Impact of blood count recovery on outcomes of acute myeloid leukemia patients achieving morphologic leukemia-free state

Blood Cancer J. 2018 Jun 7;8(6):53. doi: 10.1038/s41408-018-0094-3.

Authors

Wen-Yan Cheng¹, Yong-Mei Zhu¹, Zhao Liu¹, Xiang-Qin Weng¹, Jing-Ni Sui¹, Yun-Shuo Chen¹, Shi-Yang Wang¹, Yang Shen²

Affiliations

¹ Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. shen_yang@126.com.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers
Blood Cell Count
Combined Modality Therapy
Disease-Free Survival
Humans
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute / blood*
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / mortality*
Leukemia, Myeloid, Acute / therapy
Neoplasm, Residual
Prognosis
Recurrence

Substances

Biomarkers